|Bid||8.36 x 0|
|Ask||8.37 x 0|
|Day's Range||8.30 - 8.64|
|52 Week Range||4.76 - 22.00|
|Beta (3Y Monthly)||3.99|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Yesterday, CannTrust (CTST) hinted at a big problem that not enough people are talking about, and it's suspending its cannabis sales.
Canadian cannabis companies have leapt onto U.S. stock markets, dazzling investors. Here's a rundown of industry facts and how to invest in marijuana stocks.
Overall, the cannabis sector was weak in the first ten days of July. There was a stream of negative news about the sector. Earlier this week, CannTrust (CTST) reported that Health Canada found non-compliant operations at one of its facilities. According to the press release issued by CannTrust, the company was growing cannabis in rooms […]
On Monday, CannTrust Holdings (CTST) stock fell almost 22.6%. The sell-off was driven by a negative compliance report from Health Canada.
The cannabis industry has seen a boom over the last two years because of Canada's legalization of recreational use. We make sense of this growing sector.
Cannabis companies are in a race to achieve stratospheric sales growth in the coming years, and many companies aim to reach the one billion revenue mark in the near future.
On June 18, Canaccord Genuity cut its target price on Aphria (APHA) to 16 Canadian dollars from 18 Canadian dollars. Canaccord also lowered its revenue estimates for the company.
Aphria's valuation has taken a beating. The company came under fire from short sellers due to its investment activities in Latin America. Aphria's valuation multiples have been diverging from the peer median.
On June 24, Aphria stock rose ~5.7% without any visible catalyst. The company's valuations are at an all-time low compared to its peers, which might have attracted value buyers to the stock.
Are marijuana stocks on U.S. exchanges a good buy now? The marijuana industry gets a lot of hype, but look past the smoke and analyze pot stocks on their fundamentals and technicals.
So far, Cronos Group (CRON) has delivered a 13% return in June. The company struggled to remain in the positive territory in the previous three months due to its high valuation.
The cannabis sector's current forward EV-to-EBITDA multiple is trading at a median of 19x, which has largely moved sideways over the past few months. Investors have less confidence in the cannabis sector.